-
DOJ secures record-breaking $6.8 billion in False Claims Act settlements, judgments for FY 2025
The healthcare fraud category took the lion’s share with a staggering $5.7 billion in recovered funds from FCA matters.
-
A transformational 2025 in US healthcare – and more to come in 2026
In many ways, 2025 found the healthcare sector at a crossroads, with compliance officers holding their heads.
-
Georgia man sentenced to 46 months in prison for Medicare fraud
Patrick C Moore targeted Medicare beneficiaries to accept genetic tests that were not medically necessary or eligible for reimbursement.
-
Aesculap Implant Systems to pay $38.5m to settle False Claims Act violation allegations
The settlement resolves allegations that the Pennsylvania-based company sold its knee replacement system despite knowing defects.
-
Patients Choice Laboratories pays over $9m to settle FCA allegations
The DOJ said the case demonstrates government emphasis on combating healthcare fraud, particularly through use of the FCA.
-
Podcast: Barry Posner on healthcare M&A diligence and regulatory change
Against a backdrop of uncertain times for healthcare M&A, we spoke to Barry Posner, partner at Kudman Trachten Aloe Posner LLP.
-
Pharma Congress 2025: Enforcement actions, EOs and guidance docs
Conference speakers drew attention to cases and guidance documents showcasing the Trump administration’s enforcement and policy priorities.
-
Pharma Congress 2025: Monitoring off-label use
Panelists emphasized that the healthcare programs your organization wants to offer will get better results when closely monitored and constantly improved.